1. Home
  2. COEP vs CPHC Comparison

COEP vs CPHC Comparison

Compare COEP & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • CPHC
  • Stock Information
  • Founded
  • COEP 2017
  • CPHC 1994
  • Country
  • COEP United States
  • CPHC United States
  • Employees
  • COEP N/A
  • CPHC N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • CPHC Services-Misc. Amusement & Recreation
  • Sector
  • COEP Health Care
  • CPHC Consumer Discretionary
  • Exchange
  • COEP Nasdaq
  • CPHC Nasdaq
  • Market Cap
  • COEP 72.1M
  • CPHC 83.3M
  • IPO Year
  • COEP N/A
  • CPHC 1994
  • Fundamental
  • Price
  • COEP $17.71
  • CPHC $15.25
  • Analyst Decision
  • COEP
  • CPHC
  • Analyst Count
  • COEP 0
  • CPHC 0
  • Target Price
  • COEP N/A
  • CPHC N/A
  • AVG Volume (30 Days)
  • COEP 44.7K
  • CPHC 1.8K
  • Earning Date
  • COEP 11-14-2025
  • CPHC 11-06-2025
  • Dividend Yield
  • COEP N/A
  • CPHC 1.85%
  • EPS Growth
  • COEP N/A
  • CPHC N/A
  • EPS
  • COEP N/A
  • CPHC N/A
  • Revenue
  • COEP $500,996.00
  • CPHC $59,099,604.00
  • Revenue This Year
  • COEP N/A
  • CPHC N/A
  • Revenue Next Year
  • COEP N/A
  • CPHC N/A
  • P/E Ratio
  • COEP N/A
  • CPHC N/A
  • Revenue Growth
  • COEP N/A
  • CPHC N/A
  • 52 Week Low
  • COEP $2.31
  • CPHC $15.11
  • 52 Week High
  • COEP $19.19
  • CPHC $22.93
  • Technical
  • Relative Strength Index (RSI)
  • COEP 65.07
  • CPHC 39.35
  • Support Level
  • COEP $15.52
  • CPHC $15.11
  • Resistance Level
  • COEP $18.00
  • CPHC $15.50
  • Average True Range (ATR)
  • COEP 1.25
  • CPHC 0.13
  • MACD
  • COEP 0.34
  • CPHC -0.02
  • Stochastic Oscillator
  • COEP 92.40
  • CPHC 16.48

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About CPHC Canterbury Park Holding Corporation 'New'

Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.

Share on Social Networks: